Belvedere Trading
BMY icon

Belvedere Trading’s Bristol-Myers Squibb BMY Stock Holding History

Belvedere Trading’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-37,360
Closed -$2.21M – 59
2014
Q4 		$2.21M Buy
+37,360
New +$2.11M 0.02% 58

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Belvedere Trading's BMY Position: Q1 2015 in Review

Belvedere Trading sold out of Bristol-Myers Squibb (BMY) in Q1 2015, closing a stake of 37,360 shares — an estimated $2.21M sold.

Belvedere Trading first reported a position in BMY in Q4 2014 and held it in 1 quarter. The position peaked at $2.21M in Q4 2014. 1,449 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Belvedere Trading reported no remaining Bristol-Myers Squibb position as of Q1 2015 after selling out during the quarter.
  • Belvedere Trading sold 37,360 Bristol-Myers Squibb shares in Q1 2015, an estimated $2.21M.
  • Belvedere Trading first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 1 quarter.
  • Belvedere Trading's Bristol-Myers Squibb position peaked at $2.21M in Q4 2014.
  • 1,449 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.